Global Enteric Disease Testing and Therapeutic Market Size, Status and Forecast 2024-2031

Report ID: 954758 | Published Date: Mar 2026 | No. of Page: 99 | Base Year: 2025 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Bacterial Disease
        1.2.3 Viral Disease
        1.2.4 Parasitic Disease
    1.3 Market by Application
        1.3.1 Global Enteric Disease Testing and Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Specialty Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Enteric Disease Testing and Therapeutic Market Perspective (2016-2027)
    2.2 Enteric Disease Testing and Therapeutic Growth Trends by Regions
        2.2.1 Enteric Disease Testing and Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Enteric Disease Testing and Therapeutic Historic Market Share by Regions (2016-2021)
        2.2.3 Enteric Disease Testing and Therapeutic Forecasted Market Size by Regions (2022-2027)
    2.3 Enteric Disease Testing and Therapeutic Industry Dynamic
        2.3.1 Enteric Disease Testing and Therapeutic Market Trends
        2.3.2 Enteric Disease Testing and Therapeutic Market Drivers
        2.3.3 Enteric Disease Testing and Therapeutic Market Challenges
        2.3.4 Enteric Disease Testing and Therapeutic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue
        3.1.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue (2016-2021)
        3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2016-2021)
    3.2 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
    3.4 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
        3.4.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2020
    3.5 Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
    3.6 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
    3.7 Date of Enter into Enteric Disease Testing and Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Enteric Disease Testing and Therapeutic Breakdown Data by Type
    4.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2016-2021)
    4.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2022-2027)

5 Enteric Disease Testing and Therapeutic Breakdown Data by Application
    5.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2016-2021)
    5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Enteric Disease Testing and Therapeutic Market Size (2016-2027)
    6.2 North America Enteric Disease Testing and Therapeutic Market Size by Type
        6.2.1 North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
        6.2.2 North America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
        6.2.3 North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
    6.3 North America Enteric Disease Testing and Therapeutic Market Size by Application
        6.3.1 North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
        6.3.2 North America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
        6.3.3 North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
    6.4 North America Enteric Disease Testing and Therapeutic Market Size by Country
        6.4.1 North America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
        6.4.2 North America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Enteric Disease Testing and Therapeutic Market Size (2016-2027)
    7.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type
        7.2.1 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
        7.2.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
        7.2.3 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
    7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application
        7.3.1 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
        7.3.2 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
        7.3.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
    7.4 Europe Enteric Disease Testing and Therapeutic Market Size by Country
        7.4.1 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
        7.4.2 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size (2016-2027)
    8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type
        8.2.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application
        8.3.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region
        8.4.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Enteric Disease Testing and Therapeutic Market Size (2016-2027)
    9.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Type
        9.2.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
        9.2.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
        9.2.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
    9.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Application
        9.3.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
        9.3.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
        9.3.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
    9.4 Latin America Enteric Disease Testing and Therapeutic Market Size by Country
        9.4.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
        9.4.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size (2016-2027)
    10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type
        10.2.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application
        10.3.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country
        10.4.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Enteric Disease Testing and Therapeutic Introduction
        11.1.4 Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Details
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Introduction
        11.2.4 GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 Becton Dickinson
        11.3.1 Becton Dickinson Company Details
        11.3.2 Becton Dickinson Business Overview
        11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Introduction
        11.3.4 Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.3.5 Becton Dickinson Recent Development
    11.4 bioMérieux
        11.4.1 bioMérieux Company Details
        11.4.2 bioMérieux Business Overview
        11.4.3 bioMérieux Enteric Disease Testing and Therapeutic Introduction
        11.4.4 bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.4.5 bioMérieux Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Details
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Enteric Disease Testing and Therapeutic Introduction
        11.5.4 Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.5.5 Sanofi Recent Development
    11.6 Bayer Pharma
        11.6.1 Bayer Pharma Company Details
        11.6.2 Bayer Pharma Business Overview
        11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Introduction
        11.6.4 Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.6.5 Bayer Pharma Recent Development
    11.7 Bio-Rad
        11.7.1 Bio-Rad Company Details
        11.7.2 Bio-Rad Business Overview
        11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Introduction
        11.7.4 Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.7.5 Bio-Rad Recent Development
    11.8 Quest Diagnostics
        11.8.1 Quest Diagnostics Company Details
        11.8.2 Quest Diagnostics Business Overview
        11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Introduction
        11.8.4 Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.8.5 Quest Diagnostics Recent Development
    11.9 Trinity Biotech
        11.9.1 Trinity Biotech Company Details
        11.9.2 Trinity Biotech Business Overview
        11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Introduction
        11.9.4 Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
        11.9.5 Trinity Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Bacterial Disease
    Table 3. Key Players of Viral Disease
    Table 4. Key Players of Parasitic Disease
    Table 5. Global Enteric Disease Testing and Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Enteric Disease Testing and Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2016-2021)
    Table 9. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2022-2027)
    Table 11. Enteric Disease Testing and Therapeutic Market Trends
    Table 12. Enteric Disease Testing and Therapeutic Market Drivers
    Table 13. Enteric Disease Testing and Therapeutic Market Challenges
    Table 14. Enteric Disease Testing and Therapeutic Market Restraints
    Table 15. Global Enteric Disease Testing and Therapeutic Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Enteric Disease Testing and Therapeutic Market Share by Players (2016-2021)
    Table 17. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2020)
    Table 18. Ranking of Global Top Enteric Disease Testing and Therapeutic Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Enteric Disease Testing and Therapeutic Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
    Table 22. Date of Enter into Enteric Disease Testing and Therapeutic Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2016-2021)
    Table 26. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Enteric Disease Testing and Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2016-2021)
    Table 30. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Enteric Disease Testing and Therapeutic Product
    Table 65. Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. GlaxoSmithKline Company Details
    Table 68. GlaxoSmithKline Business Overview
    Table 69. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product
    Table 70. GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 71. GlaxoSmithKline Recent Development
    Table 72. Becton Dickinson Company Details
    Table 73. Becton Dickinson Business Overview
    Table 74. Becton Dickinson Enteric Disease Testing and Therapeutic Product
    Table 75. Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 76. Becton Dickinson Recent Development
    Table 77. bioMérieux Company Details
    Table 78. bioMérieux Business Overview
    Table 79. bioMérieux Enteric Disease Testing and Therapeutic Product
    Table 80. bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 81. bioMérieux Recent Development
    Table 82. Sanofi Company Details
    Table 83. Sanofi Business Overview
    Table 84. Sanofi Enteric Disease Testing and Therapeutic Product
    Table 85. Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 86. Sanofi Recent Development
    Table 87. Bayer Pharma Company Details
    Table 88. Bayer Pharma Business Overview
    Table 89. Bayer Pharma Enteric Disease Testing and Therapeutic Product
    Table 90. Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 91. Bayer Pharma Recent Development
    Table 92. Bio-Rad Company Details
    Table 93. Bio-Rad Business Overview
    Table 94. Bio-Rad Enteric Disease Testing and Therapeutic Product
    Table 95. Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 96. Bio-Rad Recent Development
    Table 97. Quest Diagnostics Company Details
    Table 98. Quest Diagnostics Business Overview
    Table 99. Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 100. Quest Diagnostics Recent Development
    Table 101. Trinity Biotech Company Details
    Table 102. Trinity Biotech Business Overview
    Table 103. Trinity Biotech Enteric Disease Testing and Therapeutic Product
    Table 104. Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
    Table 105. Trinity Biotech Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Enteric Disease Testing and Therapeutic Market Share by Type: 2020 VS 2027
    Figure 2. Bacterial Disease Features
    Figure 3. Viral Disease Features
    Figure 4. Parasitic Disease Features
    Figure 5. Global Enteric Disease Testing and Therapeutic Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Specialty Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Enteric Disease Testing and Therapeutic Report Years Considered
    Figure 10. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Enteric Disease Testing and Therapeutic Market Share by Regions: 2020 VS 2027
    Figure 13. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2022-2027)
    Figure 14. Global Enteric Disease Testing and Therapeutic Market Share by Players in 2020
    Figure 15. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Enteric Disease Testing and Therapeutic Revenue in 2020
    Figure 17. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2016-2021)
    Figure 18. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2022-2027)
    Figure 19. North America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
    Figure 21. North America Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
    Figure 22. North America Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
    Figure 23. United States Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
    Figure 27. Europe Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
    Figure 28. Europe Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
    Figure 29. Germany Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Region (2016-2027)
    Figure 39. China Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
    Figure 47. Latin America Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
    Figure 48. Latin America Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
    Figure 49. Mexico Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
    Figure 55. Turkey Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 60. Becton Dickinson Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 61. bioMérieux Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 62. Sanofi Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 63. Bayer Pharma Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 64. Bio-Rad Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 65. Quest Diagnostics Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 66. Trinity Biotech Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Frequently Asked Questions
Enteric Disease Testing and Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Enteric Disease Testing and Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Enteric Disease Testing and Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports